These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
166 related articles for article (PubMed ID: 24823643)
1. In vivo biodistribution of radiolabeled MMP-2/9 activatable cell-penetrating peptide probes in tumor-bearing mice. van Duijnhoven SM; Robillard MS; Nicolay K; Grüll H Contrast Media Mol Imaging; 2015; 10(1):59-66. PubMed ID: 24823643 [TBL] [Abstract][Full Text] [Related]
2. Tumor targeting of MMP-2/9 activatable cell-penetrating imaging probes is caused by tumor-independent activation. van Duijnhoven SM; Robillard MS; Nicolay K; Grüll H J Nucl Med; 2011 Feb; 52(2):279-86. PubMed ID: 21233187 [TBL] [Abstract][Full Text] [Related]
3. Imaging of MMP activity in postischemic cardiac remodeling using radiolabeled MMP-2/9 activatable peptide probes. van Duijnhoven SM; Robillard MS; Hermann S; Kuhlmann MT; Schäfers M; Nicolay K; Grüll H Mol Pharm; 2014 May; 11(5):1415-23. PubMed ID: 24641497 [TBL] [Abstract][Full Text] [Related]
4. Development of Radiolabeled Membrane Type-1 Matrix Metalloproteinase Activatable Cell Penetrating Peptide Imaging Probes. van Duijnhoven SM; Robillard MS; Nicolay K; Grüll H Molecules; 2015 Jul; 20(7):12076-92. PubMed ID: 26147581 [TBL] [Abstract][Full Text] [Related]
5. Enhancing cellular uptake of activable cell-penetrating peptide-doxorubicin conjugate by enzymatic cleavage. Shi NQ; Gao W; Xiang B; Qi XR Int J Nanomedicine; 2012; 7():1613-21. PubMed ID: 22619516 [TBL] [Abstract][Full Text] [Related]
6. Dual targeting of integrin αvβ3 and matrix metalloproteinase-2 for optical imaging of tumors and chemotherapeutic delivery. Crisp JL; Savariar EN; Glasgow HL; Ellies LG; Whitney MA; Tsien RY Mol Cancer Ther; 2014 Jun; 13(6):1514-25. PubMed ID: 24737028 [TBL] [Abstract][Full Text] [Related]
7. Performance of a new fluorescence-labeled MMP inhibitor to image tumor MMP activity in vivo in comparison to an MMP-activatable probe. Waschkau B; Faust A; Schäfers M; Bremer C Contrast Media Mol Imaging; 2013; 8(1):1-11. PubMed ID: 23109387 [TBL] [Abstract][Full Text] [Related]
8. Gelatinase activity imaged by activatable cell-penetrating peptides in cell-based and in vivo models of stroke. Chen S; Cui J; Jiang T; Olson ES; Cai QY; Yang M; Wu W; Guthrie JM; Robertson JD; Lipton SA; Ma L; Tsien RY; Gu Z J Cereb Blood Flow Metab; 2017 Jan; 37(1):188-200. PubMed ID: 26681768 [TBL] [Abstract][Full Text] [Related]
9. Radioiodinated Peptidic Imaging Probes for in Vivo Detection of Membrane Type-1 Matrix Metalloproteinase in Cancers. Kondo N; Temma T; Shimizu Y; Ono M; Saji H Biol Pharm Bull; 2015; 38(9):1375-82. PubMed ID: 26328493 [TBL] [Abstract][Full Text] [Related]
10. Detection and monitoring of localized matrix metalloproteinase upregulation in a murine model of asthma. Felsen CN; Savariar EN; Whitney M; Tsien RY Am J Physiol Lung Cell Mol Physiol; 2014 Apr; 306(8):L764-74. PubMed ID: 24508733 [TBL] [Abstract][Full Text] [Related]
11. Protease-Activable Cell-Penetrating Peptide-Protoporphyrin Conjugate for Targeted Photodynamic Therapy in Vivo. Li SY; Cheng H; Qiu WX; Liu LH; Chen S; Hu Y; Xie BR; Li B; Zhang XZ ACS Appl Mater Interfaces; 2015 Dec; 7(51):28319-29. PubMed ID: 26634784 [TBL] [Abstract][Full Text] [Related]
12. Optical imaging of matrix metalloproteinase-2 activity in tumors: feasibility study in a mouse model. Bremer C; Bredow S; Mahmood U; Weissleder R; Tung CH Radiology; 2001 Nov; 221(2):523-9. PubMed ID: 11687699 [TBL] [Abstract][Full Text] [Related]
13. In vivo characterization of activatable cell penetrating peptides for targeting protease activity in cancer. Olson ES; Aguilera TA; Jiang T; Ellies LG; Nguyen QT; Wong EH; Gross LA; Tsien RY Integr Biol (Camb); 2009 Jun; 1(5-6):382-93. PubMed ID: 20023745 [TBL] [Abstract][Full Text] [Related]
14. In vivo fluorescence imaging of atherosclerotic plaques with activatable cell-penetrating peptides targeting thrombin activity. Olson ES; Whitney MA; Friedman B; Aguilera TA; Crisp JL; Baik FM; Jiang T; Baird SM; Tsimikas S; Tsien RY; Nguyen QT Integr Biol (Camb); 2012 Jun; 4(6):595-605. PubMed ID: 22534729 [TBL] [Abstract][Full Text] [Related]
15. The targeted transduction of MMP-overexpressing tumor cells by ACPP-HPMA copolymer-coated adenovirus conjugates. Li S; Chen J; Xu H; Long J; Xie X; Zhang Y PLoS One; 2014; 9(7):e100670. PubMed ID: 25000246 [TBL] [Abstract][Full Text] [Related]
16. [The design and enzymatic hydrolysis of activatable cell-penetrating peptide]. Wang PC; Qi XR Yao Xue Xue Bao; 2010 Aug; 45(8):1048-51. PubMed ID: 21351594 [TBL] [Abstract][Full Text] [Related]
17. A dual inhibitor of matrix metalloproteinases and a disintegrin and metalloproteinases, [¹⁸F]FB-ML5, as a molecular probe for non-invasive MMP/ADAM-targeted imaging. Matusiak N; Castelli R; Tuin AW; Overkleeft HS; Wisastra R; Dekker FJ; Prély LM; Bischoff R; van Waarde A; Dierckx RA; Elsinga PH Bioorg Med Chem; 2015 Jan; 23(1):192-202. PubMed ID: 25438884 [TBL] [Abstract][Full Text] [Related]
18. In vivo positron emission tomography imaging of protease activity by generation of a hydrophobic product from a noninhibitory protease substrate. Chuang CH; Chuang KH; Wang HE; Roffler SR; Shiea JT; Tzou SC; Cheng TC; Kao CH; Wu SY; Tseng WL; Cheng CM; Hou MF; Wang JM; Cheng TL Clin Cancer Res; 2012 Jan; 18(1):238-47. PubMed ID: 22019516 [TBL] [Abstract][Full Text] [Related]
19. Inhibition of human lung cancer cells by anti-p21Ras scFv mediated by the activatable cell-penetrating peptide. Du Y; Lin X; Feng Q; Pan X; Song S; Yang J Anticancer Drugs; 2022 Jan; 33(1):e562-e572. PubMed ID: 34338241 [TBL] [Abstract][Full Text] [Related]